Skip to main content
Clinical Trials/NCT00818116
NCT00818116CompletedPhase 4

Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric Intraocular Lens (IOL): Postmarket Evaluation

Alcon Research2 sites in 1 country34 target enrollmentStarted: December 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
34
Locations
2
Primary Endpoint
Uncorrected and Best Corrected Visual Acuities (Near and Distance)

Study Overview

Brief Summary

The objective of this study is to evaluate postoperative visual function in patients implanted bilaterally with the ReSTOR Aspheric Intraocular Lens (IOL).

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
50 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Bilateral cataract patients who require natural crystalline lens removal and bilateral Intraocular Lens (IOL) implantation.
  • 50~75 years of age
  • <1 Diopter of astigmatism preoperatively (before surgery) as measured by Keratometry readings.

Exclusion Criteria

  • Patients with pre-existing conditions that could skew the results.
  • Any of conditions before and during surgery specified in the product information.

Outcomes

Primary Outcomes

Uncorrected and Best Corrected Visual Acuities (Near and Distance)

Time Frame: 6 Months Following Cataract Surgery

Measurement of uncorrected (without spectacles or other visual corrective devices) and best-corrected (with spectacles or other visual corrective devices)visual acuity at both near and distance. Visual Acuity (VA) is measured in logMAR. LogMAR is the "logarithm of the minimum angle of resolution". A lower logMAR value indicates better visual acuity.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Industry

Study Sites (2)

Loading locations...

Similar Trials

Visual Function Evaluation of Bilateral... | Clinical Trial